| 发明名称 |
Use of activated coagulation factor VII for treating thrombolytic therapy-induced major bleedings |
| 摘要 |
Major bleedings induced by thrombolytic/fibrinolytic therapy, including intracranial haemorrhages, are treated by administering to a subject suffering from such bleedings an effective amount of activated coagulation factor VII (VIIa) or of a functional derivative thereof. (62) Divided Out of 526461
|
| 申请公布号 |
NZ549850(A) |
申请公布日期 |
2008.04.30 |
| 申请号 |
NZ20010549850 |
申请日期 |
2001.12.20 |
| 申请人 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG. |
发明人 |
SKAMIRA, CORD;STASSEN, JEAN MARIE;HEUSAL, GERHARD;WIENEN, WOLFGANG |
| 分类号 |
A61K38/00;A61K38/48;A61P7/04;(IPC1-7):A61K38/48 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
